These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 17219148
1. Mechanism of antitumor effect on mouse hepatocellular carcinoma by intratumoral injection of OK-432, a streptococcal preparation. Homma S, Sagawa Y, Komita H, Koido S, Nagasaki E, Ryoma Y, Okamoto M. Cancer Immunol Immunother; 2007 Aug; 56(8):1265-74. PubMed ID: 17219148 [Abstract] [Full Text] [Related]
8. Enhancement of anti-cancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Streptococcus. Okamoto M, Ohe G, Oshikawa T, Furuichi S, Nishikawa H, Tano T, Ahmed SU, Yoshida H, Moriya Y, Saito M, Sato M. Cancer Immunol Immunother; 2001 Oct; 50(8):408-16. PubMed ID: 11726135 [Abstract] [Full Text] [Related]
10. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)]. Saito M, Yamaguchi T, Aonuma E, Noda T, Edina T, Ishida N. Gan To Kagaku Ryoho; 1982 Nov; 9(11):2031-7. PubMed ID: 6820888 [Abstract] [Full Text] [Related]
13. Protective antitumor immunity induced by fixed tumor cells in combination with adjuvant in a murine hepatoma model. Huang L, Ohno T. Cancer Lett; 2003 Dec 30; 202(2):153-9. PubMed ID: 14643445 [Abstract] [Full Text] [Related]
20. Involvement of nitric oxide in anti-tumor effects of OK-432, a streptococcal anti-tumor immunotherapeutic agent. Oshikawa T, Okamoto M, Tano T, Uddin Ahmed S, Sasai A, Kan S, Moriya Y, Ryoma Y, Saito M, Sato M. Int Immunopharmacol; 2006 May 30; 6(5):764-73. PubMed ID: 16546707 [Abstract] [Full Text] [Related] Page: [Next] [New Search]